Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML https://www.biorxiv.org/content/10.1101/2023.03.13.531236v1?med=mas
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML https://www.biorxiv.org/content/10.1101/2023.03.13.531236v1?med=mas